由GLP-1激动剂诱导的自身免疫性胰腺炎
Jasmin Mahajne1, Ernestina Angarola2, Emanuel Della Torre1,3
1Unit of Immunology, Rheumatology, Allergy and Rare Diseases, UnIRAR, IRCCS Ospedale San Raffaele, Milan, Italy.
BMJ case reports
|September 24, 2025
概括
葡萄糖类 (GLP) -1 激动剂可能会在敏感个体中引发1型自身免疫性胰腺炎 (AIP). 研究人员建议替代性胰岛素治疗2型糖尿病患者的1型AIP,以防止复发.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 自身免疫性胰腺炎 (AIP) 呈现为1型 (IgG4相关疾病) 和2型 (与炎症性肠病相关的炎症性肠病).
- 最近,第三种类型的AIP与免疫检查点抑制剂有关.
研究的目的:
- 在2型糖尿病 (DM) 治疗葡萄糖类 (GLP) -1 激动剂后报告3例1型AIP.
- 探索GLP-1激动剂在1型AIP的发展和复发中的潜在作用.
主要方法:
- 一系列病例报告了三名患者在GLP-1激动剂治疗后出现1型AIP.
- 关于GLP-1激动剂对胰腺和胆道系统的影响的文献综述.
主要成果:
- 在接受GLP-1激动剂治疗的2型糖尿病患者中观察到3例1型AIP.
- GLP-1激动剂可能会影响胰腺缩,细胞代谢和抗原呈现,可能会在易感个体中触发1型AIP.
结论:
- GLP-1激动剂可能与1型AIP的发病有关.
- 在使用GLP-1激动剂的1型AIP患者中,胰腺炎的复发是假设的.
- 基于胰岛素的疗法可能更适合2型DM患者,同时存在1型AIP.
相关概念视频
Glucagon-like Receptor Agonists
848
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
848
Chronic Pancreatitis I: Introduction
667
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
667
Acute Pancreatitis I: Introduction
1.1K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.1K
Gastritis-II: Pathophysiology
1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Dipeptidyl Peptidase 4 Inhibitors
594
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
594
Acute Pancreatitis II: Clinical Manifestations and Management
756
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
756


